Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
LILRB2 VHH recombinant monoclonal antibody
LILRB4 VHH recombinant monoclonal antibody
LINGO1 VHH recombinant monoclonal antibody
LOXL2 VHH recombinant monoclonal antibody
LRRC15 VHH recombinant monoclonal antibody
LRRC32 VHH recombinant monoclonal antibody
LTA VHH recombinant monoclonal antibody
LY75 VHH recombinant monoclonal antibody
LYPD3 VHH recombinant monoclonal antibody
MADCAM1 VHH recombinant monoclonal antibody
MAG VHH recombinant monoclonal antibody
MASP2 VHH recombinant monoclonal antibody